MIBAVADEMAB
UNII PHL2UDY3AB

Substance Identification & Data

This profile provides standardized clinical and technical data for Mibavademab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PHL2UDY3AB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2305770-44-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

PHL2UDY3AB

CAS Registry Number

2305770-44-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MIBAVADEMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C179103

National Cancer Institute reference terminology for clinical and research data.

INN ID

11510

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mibavademab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MIBAVADEMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4 (227-PROLINE), ANTI-(HUMAN LEPTIN RECEPTOR) (HUMAN MONOCLONAL REGN4461 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN4461 .KAPPA.-CHAIN, DIMER

MIBAVADEMAB [INN]